IP Library Granted Patent US 10,526,663
Granted Patent B2
US 10,526,663 · App. 15/119,987 · Granted Jan 7, 2020

Method of detecting a microorganism in a sample by a fluorescence based detection method

Inventors: Anne Baumstummler (Gertwiller, FR); Frederic Marc-Kreucher (Itterswiller, FR); David Lehmann (Andolsheim, FR); Urs Ochsner (Denver, CO); Nebojsa Janjic (Boulder, CO)
Assignees: Merck Patent GmbH; SOMALOGIC, Inc.
C12Q1/689G01N15/1436G01N21/6428G01N2015/0065G01N2021/6439G01N2201/06113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,526,663
App. No.
15/119,987
Granted
Jan 7, 2020
Kind
B2
Abstract

The present invention relates to a method of detecting a microorganism, in particular Staphylococcus aureus , in a sample, comprising the steps of a) incubating the sample with a slow off-rate modified aptamer (SOMAmer) comprising a fluorescent label, b) optionally washing the sample, c) analyzing the sample by a fluorescence-based detection method. The invention further relates to a slow off-rate modified aptamer comprising a fluorescent label, wherein the SOMAmer comprises a nucleotide sequence specific for Staphylococcus aureus , its use for detecting Staphylococcus aureus cells in a sample, and to a microarray or biosensor and a kit comprising at least one of such SOMAmers comprising a fluorescent label.

Claims (13)

1. A method of detecting a microorganism in a sample, comprising

a) incubating the sample with a slow off-rate modified aptamer (SOMAmer) comprising a fluorescent label,

b) optionally washing the sample,

c) analyzing the sample by a fluorescence-based detection method,

wherein the SOMAmer comprises

the nucleotide sequence of SEQ ID NO:1, or

the nucleotide sequence which is fully complementary to SEQ ID NO:1,

wherein the microorganism is Staphylococcus aureus.

2. The method of claim 1 , wherein the fluorescence-based detection method is a method selected from the group consisting of flow cytometry, solid-phase cytometry, fluorescence-based analytical methods, and fluorescence imaging system.

3. The method of claim 1 , wherein the sample is a clinical sample, a food or feed sample, a beverage sample, a pharmaceutical sample, a personal care or cosmetic sample and/or a water sample.

4. The method of claim 1 , wherein the SOMAmer comprises a nucleotide sequence specific for Staphylococcus aureus.

5. The method of claim 1 , wherein the fluorescent label is selected from the group consisting of fluorescein dyes rhodamine dyes, cyanine dyes, Peridinin chlorophyll (PerCP), R-Phycoerythrin, coumarine dyes and quantum dots.

6. The method of claim 1 , wherein the SOMAmer comprises the nucleotide sequence of SEQ ID NO:1.

Assignments (5)
CHANGE OF NAME Recorded Oct 6, 2022
From: SOMALOGIC, INC.
To: SOMALOGIC OPERATING CO., INC.
Reel/Frame 061621/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: MILLIPORE SAS
To: EMD MILLIPORE CORPORATION
Reel/Frame 042707/0327 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: EMD MILLIPORE CORPORATION
To: MERCK PATENT GMBH
Reel/Frame 042707/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2017
From: OCHSNER, URS; JANJIC, NEBOJSA
To: MERCK PATENT GMBH; SOMALOGIC, INC.
Reel/Frame 042692/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2017
From: BAUMSTUMMLER, ANNE; MARC-KREUCHER, FREDERIC; LEHMANN, DAVID
To: MILLIPORE SAS
Reel/Frame 042693/0390 →
Priority Claims (2)
EP 14290046 · Feb 21, 2014 · regional
EP 14290047 · Feb 21, 2014 · regional
Continuity (1)
Related Publication 20170051337A1 · Feb 23, 2017